JEWISH TIME PODCAST JEWISH TIME PODCAST SUBSCRIBE TODAY SUBSCRIBE TODAY
search
US Food and Drug Administration (FDA)
Parents nationally have generally been slow to accept the vaccine for children aged five to 11.
February 24, 2022, 5:51 pm
Vaccine Not FDA-Approved for Kids Under Five
Government regulators want more information before approving the Pfizer and BioNTech Vaccine for those under five.
By Bob Bahr
This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)
October 26, 2021, 10:47 am
FDA Expected to Authorize Pfizer COVID Vaccine for Kids 5-11
Israel planning to follow suit after its own approval process, as soon as mid-November.
By AFP and TOI STAFF
Israelis aged 60+ receive their third dose of the COVID-19 vaccine at a temporary Clalit health care center in Tel Aviv, on August 10, 2021. (Miriam Alster/Flash90)
August 10, 2021, 5:10 pm
3rd COVID Shot Highly Potent in Israel’s Immunocompromised, Early Study Shows
Beilinson Medical Center research finds third vaccine dose doubled number of organ transplant recipients who developed antibodies as compared to first 2 doses.
By TOI STAFF
In this photo one vial of the drug Remdesivir is viewed during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic. - Gilead Science's remdesivir, one of the most highly anticipated drugs being tested against the new coronavirus, showed positive results in a large-scale US government trial, the company said on April 29, 2020."We understand that the trial has met its primary endpoint and that NIAID (National Institute of Allergy and Infectious Diseases) will provide detailed information at an upcoming briefing," the company said. (Photo by Ulrich Perrey / POOL / AFP)
May 4, 2020, 7:21 am
Remdesivir Results for Virus Encouraging but too Early to Celebrate
FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear.
By TOI Staff and AP
Load More